Patents by Inventor Hironao NAKAYAMA

Hironao NAKAYAMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230256053
    Abstract: The methods and uses described herein relate to the modulation of the immune system by modulation of Sema3F levels and/or activity, e.g. suppressing allograft rejection or inflammation by administering a Sema3F agonist or increasing an immune response by administering a Sema3F inhibitor.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 17, 2023
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David M. BRISCOE, Michael KLAGSBRUN, Sarah BRUNEAU, Nora KOCHUPURAKKAL, Hironao NAKAYAMA
  • Publication number: 20190388505
    Abstract: The methods and uses described herein relate to the modulation of the immune system by modulation of Sema3F levels and/or activity, e.g. suppressing allograft rejection or inflammation by administering a Sema3F agonist or increasing an immune response by administering a Sema3F inhibitor.
    Type: Application
    Filed: September 5, 2019
    Publication date: December 26, 2019
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David M. BRISCOE, Michael KLAGSBRUN, Sarah BRUNEAU, Nora KOCHUPURAKKAL, Hironao NAKAYAMA
  • Patent number: 10456445
    Abstract: The methods and uses described herein relate to the modulation of the immune system by modulation of Sema3F levels and/or activity, e.g. suppressing allograft rejection or inflammation by administering a Sema3F agonist or increasing an immune response by administering a Sema3F inhibitor.
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: October 29, 2019
    Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David M. Briscoe, Michael Klagsbrun, Sarah Bruneau, Nora Kochupurakkal, Hironao Nakayama
  • Publication number: 20170100456
    Abstract: The methods and uses described herein relate to the modulation of the immune system by modulation of Sema3F levels and/or activity, e.g. suppressing allograft rejection or inflammation by administering a Sema3F agonist or increasing an immune response by administering a Sema3F inhibitor.
    Type: Application
    Filed: June 1, 2015
    Publication date: April 13, 2017
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David M. BRISCOE, Michael KLAGSBRUN, Sarah BRUNEAU, Nora KOCHUPURAKKAL, Hironao NAKAYAMA